Episode Summary:Benoy Thanjan sits down with his co-host Nate Jovanelly, Founder & CEO of SunRaise Capital, to break down how the Big Beautiful Bill is reshaping residential solar. They discuss Section 25D’s removal, the surge in solar + storage, and innovative financing models like prepaid leases. Biographies Benoy Thanjan Benoy Thanjan is the Founder and CEO of Reneu Energy, and a strategic advisor to multiple clean energy startups. Over his career, Benoy has developed over 100 MWs of solar

Ubuntu in Modern Society: The Power of Connection and Compassion

Host: Gerard A. Silvestri MD, MS, Master FCCP Guest: Jeffrey B. Velotta, MD, FACS Guest: Anne Gonzalez, MD, M.Sc. For patients with non-small cell lung cancer, staging accuracy is critical in guiding treatment decisions that can significantly affect outcomes. In this expert-led discussion, Dr. Gerard Silvestri sits down with Drs. Anne Gonzalez and Jeffrey Velotta break down what clinicians need to know, including how to perform thorough EBUS staging, why PET scans alone aren’t

Host: Gerard A. Silvestri MD, MS, Master FCCP Guest: Fabien Maldonado, MD, FCCP Guest: Adam H. Fox, MD, MSc Cutting-edge biopsy methods and streamlined biomarker testing are transforming early-stage non-small cell lung cancer (NSCLC) care. Hear from Drs. Gerard Silvestri, Fabien Maldonado, and Adam Fox as they discuss the evolution of bronchoscopic techniques, insights from landmark trials, and the role of pragmatic clinical research in refining biopsy approaches. Dr. Silvestri

Host: Ryan Quigley Guest: Hallie Blevins, PhD. Guest: Marlene Mimi Maeusli, PhD. With one in three eligible Americans still unscreened for colorectal cancer (CRC), there’s an urgent need for noninvasive and affordable alternatives to colonoscopy. A 2025 study published in ACS Sensors introduces a novel aptamer-based colorimetric assay that targets Parvimonas micra—a gut microbe linked to CRC. To learn more, Mr. Ryan Quigley speaks with Drs. Hallie Blevins and Mimi Maeusli about

Host: Ryan Quigley Guest: Hallie Blevins, PhD. Guest: Marlene Mimi Maeusli, PhD. With one in three eligible Americans still unscreened for colorectal cancer (CRC), there’s an urgent need for noninvasive and affordable alternatives to colonoscopy. A 2025 study published in ACS Sensors introduces a novel aptamer-based colorimetric assay that targets Parvimonas micra—a gut microbe linked to CRC. To learn more, Mr. Ryan Quigley speaks with Drs. Hallie Blevins and Mimi Maeusli about

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Jacqueline Wong, MD, MSCR, FACOG For patients with endometriosis, treatment delays can profoundly impact both quality of life and clinical outcomes. Proactive strategies that address logistical barriers—such as prior authorizations—combined with education and multidisciplinary support are essential in improving care. Join Dr. Charles Turck and Dr. Jacqueline Wong as they explore practical approaches for managing this complex condition

Nelson hospital health upgrade the hospital didn’t seem keen on - The carbon bootprint of war a flashback to CM 72 - SaveBOARD revisited: well worth a closer look - From the “can you believe it?” files: a tree that rocks. - Our World in Data gives deeper insights into food and climate - A longer read - Now you see it now you don’t: seeking good adaptation policy https://climatemattersnz.substack.com/p/climate-matters-136

Since 2010, the landscape of multiple sclerosis care has transformed to encompass a variety of medications, each having unique benefits, risks, and side effect profiles. Dr. Jonathan Howard discusses how to match treatment strength to disease severity and balance patient risk tolerance with evolving therapeutic options, from long-standing injectables to infusions and oral therapies. Dr. Howard is an Associate Professor of Neurology and Psychiatry at the NYU Grossman School of Medicine and

Early symptoms of multiple sclerosis (MS) often present as clear, localized neurological changes lasting several days. However, many nonspecific complaints and common MRI findings can mimic MS, leading to misdiagnosis and unnecessary treatment. Dr. Jonathan Howard, an Associate Professor of Neurology and Psychiatry at the NYU Grossman School of Medicine and the Director of the Neurology Service at Bellevue Hospital, reviews hallmark symptom patterns, explains how to differentiate benign

Fibrodysplasia ossificans progressiva (FOP) is a severely disabling myopathy in which extraskeletal bone forms and accumulates over time within muscles and soft tissues.1,2 Here’s what we know so far about the mechanisms of heterotopic ossification in patients with FOP. References: Kaplan FS et al. Best Pract Res Clin Rheumatol 2008;22:191–205. Pignolo RJ et al. Orphanet J Rare Dis 2011;6:80. © 2025 Ipsen Biopharmaceuticals Inc. All rights reserved. ALLSC-US-001927 | August 2025

Early symptoms of multiple sclerosis (MS) often present as clear, localized neurological changes lasting several days. However, many nonspecific complaints and common MRI findings can mimic MS, leading to misdiagnosis and unnecessary treatment. Dr. Jonathan Howard, an Associate Professor of Neurology and Psychiatry at the NYU Grossman School of Medicine and the Director of the Neurology Service at Bellevue Hospital, reviews hallmark symptom patterns, explains how to differentiate benign

Since 2010, the landscape of multiple sclerosis care has transformed to encompass a variety of medications, each having unique benefits, risks, and side effect profiles. Dr. Jonathan Howard discusses how to match treatment strength to disease severity and balance patient risk tolerance with evolving therapeutic options, from long-standing injectables to infusions and oral therapies. Dr. Howard is an Associate Professor of Neurology and Psychiatry at the NYU Grossman School of Medicine and

Monitoring island fox survival is vital to protecting the vulnerable and small populations on six separate Channel Islands. (Current island fox status)Checking for the individual radio signals from 50–60 individual island foxes across an entire island every two weeks, can require many staff hours. Reducing staffing hours would make island-fox monitoring less expensive?Enter a new technology referred to as "Digipeater." The collar pictured above is one of the 10 new Digipeater radio collars funded by

Sydney Adams, a CDC ORISE fellow, and Dr. Johanna Salzer, a veterinary medical officer and epidemiology team lead in CDC's Division of Vector-Borne Deases, discuss national surveillance of human ehrlichiosis caused by Ehrlichia ewingii in the United States.

Generalized Anxiety Disorder (GAD) Clinical Presentation Labs, Studies & Imaging Treatment & Management Panic Disorder Clinical Presentation Labs, Studies & Imaging Treatment & Management Phobias Clinical Presentation Labs, Studies & Imaging Treatment & Management Obsessive-Compulsive Disorder (OCD) Clinical Presentation Labs, Studies & Imaging Treatment & Management High-Yield FactsThe post 134: Anxiety and Obsessive-Compulsive Disorders appeared first on Physician

* On the Stand:This weekFred WilliamsandDoug McBurneywelcomeDonny Budinsky and Matt Nailor ofStanding for Truth Ministriestodiscuss the Bible,science, history and the gospel!* Startingwith the Bible:HearDonny Budinsky and Matt NailoranswerAron Ra's phylogeny challengeout of the Bible, (which happens to be confirmed by empiricalscience). * Eden , Eve, the Tree, the Ark and more...Starting with the Bible, (with references to extra-biblicalsources), wediscuss how history, literature

Eye On The Night Sky For Monday, August 18

Dr. Beth Stroupe is a Professor in the Department of Biological Science and the Institute of Molecular Biophysics at Florida State University (FSU). She is also Director of the Molecular Biophysics Graduate Program there. Research in Beth’s lab focuses on understanding what molecules and proteins look like. This is important for better understanding how these molecules work, both from a basic science perspective and with an eye towards controlling molecules for clinical applications. They use a

IPA has broadly been adopted by the life scienceresearch community and is cited in thousands of articles for the analysis, integration, and interpretation of data derived from ‘omics experiments, such as RNA-seq, small RNA-seq, microarrays including miRNA and SNP, metabolomics, proteomics, and small scale experiments. Hosted by two QIAGEN Senior Scientists, this series will show you step-by-step how to implement and use IPA to get the most out of your data. Part 3: Search and Explore in IPA Learn